{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/prov/452015904"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/266177852" ] } },

    { "id" : "http://webisa.webdatacommons.org/266177852"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "A new regulation that went into effect Aug. 18, 2003, implements another FTC recommendation, to tighten the patent submission and listing process so that only appropriate patents are submitted to the FDA. To help prevent unfair competition, the regulation clarifies the types of patents that must be submitted to the FDA. Companies must submit patent information on active ingredients, drug formulati" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "lifealert.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/19999341"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/266177852"] } } }
